A Study to Evaluate the Safety and Efficacy of OPB-101 in Platinum-resistant Ovarian Cancer
Clinical trial NCT07030907 · RECRUITING
Trial details
- NCT number
- NCT07030907
- Sponsor
- Outpace Bio, Inc.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-16
- Primary completion
- 2028-05-15
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.